Regarding “MD Anderson battles $111m deficit” (Page A1, Thursday), that a nonprofit like MD Anderson should have both an $111 million deficit and a $2.8 billion cash reserve is mysterious enough given the institution’s tax-exempt status as an agency of the state of Texas.
The article and the MD Anderson spokesman suggest that there are troubles on the revenue side with patient access to the center and with the reimbursement insurers are giving the center for its pricey care. That care is deemed to be of higher quality, but perhaps the market disagrees.
Greater examination of the expenses of MD Anderson, and more intense assessment of the value of these expenses which were purported to generate new cancer cures, are in order.
Leonard Zwelling, Bellaire